Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1131-45. doi: 10.1158/1055-9965.EPI-10-1224. Epub 2011 Mar 29.

Abstract

Background: Mitochondria contribute to oxidative stress, a phenomenon implicated in ovarian carcinogenesis. We hypothesized that inherited variants in mitochondrial-related genes influence epithelial ovarian cancer (EOC) susceptibility.

Methods: Through a multicenter study of 1,815 Caucasian EOC cases and 1,900 controls, we investigated associations between EOC risk and 128 single nucleotide polymorphisms (SNPs) from 22 genes/regions within the mitochondrial genome (mtDNA) and 2,839 nuclear-encoded SNPs localized to 138 genes involved in mitochondrial biogenesis (BIO, n = 35), steroid hormone metabolism (HOR, n = 13), and oxidative phosphorylation (OXP, n = 90) pathways. Unconditional logistic regression was used to estimate OR and 95% CI between genotype and case status. Overall significance of each gene and pathway was evaluated by using Fisher's method to combine SNP-level evidence. At the SNP level, we investigated whether lifetime ovulation, hormone replacement therapy (HRT), and cigarette smoking were confounders or modifiers of associations.

Results: Interindividual variation involving BIO was most strongly associated with EOC risk (empirical P = 0.050), especially for NRF1, MTERF, PPARGC1A, ESRRA, and CAMK2D. Several SNP-level associations strengthened after adjustment for nongenetic factors, particularly for MTERF. Statistical interactions with cigarette smoking and HRT use were observed with MTERF and CAMK2D SNPs, respectively. Overall variation within mtDNA, HOR, and OXP was not statistically significant (empirical P > 0.10).

Conclusion: We provide novel evidence to suggest that variants in mitochondrial biogenesis genes may influence EOC susceptibility.

Impact: A deeper understanding of the complex mechanisms implicated in mitochondrial biogenesis and oxidative stress may aid in developing strategies to reduce morbidity and mortality from EOC.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenocarcinoma, Clear Cell / genetics
  • Adenocarcinoma, Mucinous / genetics
  • Basic-Leucine Zipper Transcription Factors / genetics
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / genetics
  • Case-Control Studies
  • Cystadenocarcinoma, Serous / genetics
  • DNA, Mitochondrial / genetics*
  • ERRalpha Estrogen-Related Receptor
  • Endometrial Neoplasms / genetics
  • Female
  • Genes, Mitochondrial / genetics*
  • Genotype
  • Heat-Shock Proteins / genetics
  • Humans
  • Middle Aged
  • Mitochondrial Proteins / genetics
  • NF-E2-Related Factor 2 / genetics
  • Nuclear Respiratory Factor 1 / genetics
  • Ovarian Neoplasms / genetics*
  • Oxidative Stress
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Polymorphism, Single Nucleotide / genetics*
  • Receptors, Estrogen / genetics
  • Risk Factors
  • Transcription Factors / genetics

Substances

  • Basic-Leucine Zipper Transcription Factors
  • DNA, Mitochondrial
  • Heat-Shock Proteins
  • MTERF1 protein, human
  • Mitochondrial Proteins
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • NRF1 protein, human
  • Nuclear Respiratory Factor 1
  • PPARGC1A protein, human
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Receptors, Estrogen
  • Transcription Factors
  • CAMK2D protein, human
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2